Meghan Jenkins had her hands full with her toddler, Malachi. He was energetic and inquisitive, eager to explore the world around him. He loved anything to do with the Miami Dolphins and played constantly with dinosaurs and monster trucks. He was settling in at day care while jenkins returned to work after taking a year off. Life was busy, but happy.

In March 2021, Jenkins noticed Malachi was tired and lethargic. He also had a lingering cough. One day,he threw up. When Jenkins changed his diaper, she found black stool. Immediately concerned, she and Malachi went straight to the emergency room.

Things moved quickly then, Jenkins said. Malachi was “connected to all these cords.” Someone said he might need a blood transfusion. Hours passed with no answers.Jenkins grew more scared by the minute. Malachi was admitted to the pediatric intensive care unit, where doctors performed a bone marrow biopsy.

a doctor sat Jenkins down for the diagnosis: Acute lymphoblastic leukemia. She was told her little boy’s life expectancy could be just two and a half to three more years.

“In that moment, you question God. You ask him ‘Why did this happen?'” Jenkins said. “I was so lost. This was my only child. I was young still, going through life, trying to figure things out.And then I had a big hit.”

What is acute lymphoblastic leukemia?

Acute lymphoblastic leukemia, or ALL, is a rare cancer that starts in the bone marrow, according to the american Cancer Society’s website. Only about 6,100 new cases of ALL are diagnosed a year, according to the American Cancer society, with children under the age of 5 having the highest risk of developing the disease.

ALL is a fast-growing cancer that results in the body producing immature white blood cells. Malachi’s white blood cell count was more than 10 times higher than it should be. The white blood cells were crowding out healthy cells, weakening his immune system and making it impossible for

Malachi’s Story: A Remarkable Remission from Leukemia

Published: 2025/11/29 16:56:04

The Initial Diagnosis and Treatment

Malachi, a bright and energetic young boy, faced a daunting challenge when he was diagnosed with acute lymphoblastic leukemia (ALL). ALL is a type of cancer of the blood and bone marrow, affecting white blood cells. His journey began with intensive chemotherapy, a standard treatment protocol for ALL. The goal of chemotherapy is to destroy cancer cells in the body.

Understanding Acute Lymphoblastic Leukemia

• ALL is the most common type of cancer in children.
• It affects the production of healthy white blood cells.
• Treatment typically involves several phases of chemotherapy.

The Road to remission

The treatment process was rigorous, but Malachi demonstrated incredible strength and resilience. his mother, Jenkins, highlighted his continued enthusiasm for his favourite activities – cheering for the Miami Dolphins, playing with dinosaurs and trucks, and excelling in school, even while undergoing treatment. He continued to thrive academically, participating in gifted classes and consistently making the honor roll.

“He still cheers for the Dolphins and plays with dinosaurs and trucks. He’s become a big reader and loves to share fun facts.” – Jenkins, Malachi’s Mother

The Critical First Year

Dr. Barredo emphasized the importance of the first year after completing therapy. This period carries the highest risk of relapse. Malachi successfully navigated this crucial milestone, a testament to the effectiveness of his treatment and his own inner fortitude.

Life After Treatment: Continued Monitoring and Hope

While Malachi is currently in remission, ongoing monitoring is essential. Dr. Barredo explained that while the risk decreases after the first year, there remains “some risk” of relapse in the subsequent years. Regular check-ups and tests will continue to ensure his continued well-being.

Malachi Today

Despite his battle with leukemia, Malachi remains a vibrant and inquisitive child. He has embraced reading and enjoys sharing interesting facts he learns. His story is a powerful reminder of the courage and resilience of children facing cancer, and the hope that remission brings.

Key Takeaways

• Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
• Intensive chemotherapy is the primary treatment for ALL.
• The first year after treatment completion carries the highest risk of relapse.
• Continued monitoring is crucial even after achieving remission.
• Malachi’s story exemplifies the strength and hope found in the fight against childhood cancer.

Frequently Asked Questions (FAQ)

What is acute lymphoblastic leukemia (ALL)?

ALL is a type of cancer that affects the blood and bone marrow, specifically impacting the production of white blood cells.

What does “remission” mean?

Remission means that the signs and symptoms of cancer have decreased or disappeared. Though, it doesn’t necessarily mean the cancer is cured.

Is there a chance of relapse after remission?

Yes, there is a chance of relapse, especially within the first year after completing treatment. Continued monitoring is vital.

Malachi’s journey highlights the advancements in pediatric cancer treatment and the importance of ongoing research. While his story is uniquely his, it offers hope and inspiration to families facing similar challenges. Future research will continue to focus on minimizing the risk of relapse and improving the quality of life for childhood cancer survivors.